Attached files
| file | filename |
|---|---|
| 10-K - 10-K - AMAG PHARMACEUTICALS, INC. | a2196774z10-k.htm |
| EX-31.1 - EXHIBIT 31.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-31_1.htm |
| EX-32.1 - EXHIBIT 32.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - AMAG PHARMACEUTICALS, INC. | a2196774zex-31_2.htm |
| EX-32.2 - EXHIBIT 32.2 - AMAG PHARMACEUTICALS, INC. | a2196774zex-32_2.htm |
| EX-10.2 - EXHIBIT 10.2 - AMAG PHARMACEUTICALS, INC. | a2196774zex-10_2.htm |
| EX-21.1 - EXHIBIT 21.1 - AMAG PHARMACEUTICALS, INC. | a2196774zex-21_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333-164400) and in the Registration Statements on Form S-8 (File Nos. 333-82292, 333-131656, 333-143272, 333-148682 and 333-159938) of AMAG Pharmaceuticals, Inc. of our report dated February 26, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
| /s/ PRICEWATERHOUSECOOPERS LLP Boston, Massachusetts February 26, 2010 |